“Global Atrial Fibrillation Market Report 2019” report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Global Atrial Fibrillation Market Overview:

The Global Atrial Fibrillation Market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and opportunities along with their impact on the Atrial Fibrillation Market growth (2019 - 2023).

The most important key factors driving the growth of the Global Atrial Fibrillation (AF) Market are increasing prevalence of Atrial Fibrillation (AF) in geriatric population, technological advancements, and increase in preference of catheter ablation for cardiac arrhythmia treatment. Moreover, dearth of skilled professionals and unfavorable preference of pharmaceutical interventions (drugs) over Atrial Fibrillation (AF) treatment devices are expected to hinder the growth of the Atrial Fibrillation (AF) Market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/162993 .

The Global Atrial Fibrillation (AF) Market is segmented on the basis of Treatment Type, Device Type and Region. Based on the Treatment Type, the Global Atrial Fibrillation (AF) Market is classified into Non-pharmacological and Pharmacological. On the basis of Device Type, the Global Atrial Fibrillation (AF) Market is sub-segmented into Catheter Ablation Devices, Mapping and Recording Systems, Access Devices, Cardiac Monitors, Intracardiac Echocardiography (ICE) Systems, Left Atrial Appendage (LAA) and Closure Devices and others.

As per the geographic analysis, North America holds a dominant position in the market, accounting for the largest market share. APAC region is expected to be the fastest growing region with a healthy CAGR during the forecast period (2019 - 2023). Japan accounted for the highest share of the total APAC market in 2015; while China is poised to grow at highest CAGR during the analysis period. This growth in this region is attributed to the rise in the prevalence of cardiac arrhythmia in developing countries (such as India and China) owing to the large geriatric population.

Top Leading Key Players in Global Atrial Fibrillation (AF) Market: Cardiofocus, Biosense Webster, Biotitic Se & Co. Kg, St. Jude Medical, Medtronic, Carima, Boston Scientific Corporation, Ncontact, Agricore and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Latest Industry News:

St. Jude Medical (May 21, 2019) – Triluminate Study Shows Treatment with Abbott's First-of-its-kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks – Abbott (NYSE: ABT) today announced positive late-breaking data from its TRILUMINATE study of the company's minimally invasive tricuspid valve repair system. Results at 30 days demonstrated that the investigational device is associated with a reduction of tricuspid regurgitation (TR) symptoms – caused by a leaky tricuspid heart valve – suggesting a possible treatment option for people suffering from this difficult-to-manage structural heart disease. Abbott's transcatheter tricuspid valve repair (TTVR) system builds on the continued advances of the company's proven clip-based MitraClip technology, which treats people with leaky mitral valves.

Results from the TRILUMINATE study were presented in a late-breaking trial session at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

"Treating a leaky tricuspid heart valve has long presented a significant challenge for cardiologists because it is an extremely complex and difficult heart valve to treat," said Georg Nickenig, M.D., Ph.D., professor and chief, Department of Cardiology, University Hospital, Bonn, Germany, and lead investigator of the study. "These data are extremely encouraging, and I am excited about the potential of transcatheter tricuspid valve repair as a minimally invasive treatment option for these very ill patients who have no other options."

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Atrial Fibrillation in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Atrial Fibrillation Market Report 2019” @ https://www.businessindustryreports.com/buy-now/162993/single .

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940

“Global Atrial Fibrillation Market Report 2019” report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Global Atrial Fibrillation Market Overview:

The Global Atrial Fibrillation Market research report is the study prepared by analysts, which contain a detailed analysis of drivers, restraints, and opportunities along with their impact on the Atrial Fibrillation Market growth (2019 - 2023).

The most important key factors driving the growth of the Global Atrial Fibrillation (AF) Market are increasing prevalence of Atrial Fibrillation (AF) in geriatric population, technological advancements, and increase in preference of catheter ablation for cardiac arrhythmia treatment. Moreover, dearth of skilled professionals and unfavorable preference of pharmaceutical interventions (drugs) over Atrial Fibrillation (AF) treatment devices are expected to hinder the growth of the Atrial Fibrillation (AF) Market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/162993 .

The Global Atrial Fibrillation (AF) Market is segmented on the basis of Treatment Type, Device Type and Region. Based on the Treatment Type, the Global Atrial Fibrillation (AF) Market is classified into Non-pharmacological and Pharmacological. On the basis of Device Type, the Global Atrial Fibrillation (AF) Market is sub-segmented into Catheter Ablation Devices, Mapping and Recording Systems, Access Devices, Cardiac Monitors, Intracardiac Echocardiography (ICE) Systems, Left Atrial Appendage (LAA) and Closure Devices and others.

As per the geographic analysis, North America holds a dominant position in the market, accounting for the largest market share. APAC region is expected to be the fastest growing region with a healthy CAGR during the forecast period (2019 - 2023). Japan accounted for the highest share of the total APAC market in 2015; while China is poised to grow at highest CAGR during the analysis period. This growth in this region is attributed to the rise in the prevalence of cardiac arrhythmia in developing countries (such as India and China) owing to the large geriatric population.

Top Leading Key Players in Global Atrial Fibrillation (AF) Market: Cardiofocus, Biosense Webster, Biotitic Se & Co. Kg, St. Jude Medical, Medtronic, Carima, Boston Scientific Corporation, Ncontact, Agricore and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Latest Industry News:

St. Jude Medical (May 21, 2019) – Triluminate Study Shows Treatment with Abbott's First-of-its-kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks – Abbott (NYSE: ABT) today announced positive late-breaking data from its TRILUMINATE study of the company's minimally invasive tricuspid valve repair system. Results at 30 days demonstrated that the investigational device is associated with a reduction of tricuspid regurgitation (TR) symptoms – caused by a leaky tricuspid heart valve – suggesting a possible treatment option for people suffering from this difficult-to-manage structural heart disease. Abbott's transcatheter tricuspid valve repair (TTVR) system builds on the continued advances of the company's proven clip-based MitraClip technology, which treats people with leaky mitral valves.

Results from the TRILUMINATE study were presented in a late-breaking trial session at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

"Treating a leaky tricuspid heart valve has long presented a significant challenge for cardiologists because it is an extremely complex and difficult heart valve to treat," said Georg Nickenig, M.D., Ph.D., professor and chief, Department of Cardiology, University Hospital, Bonn, Germany, and lead investigator of the study. "These data are extremely encouraging, and I am excited about the potential of transcatheter tricuspid valve repair as a minimally invasive treatment option for these very ill patients who have no other options."

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Atrial Fibrillation in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Atrial Fibrillation Market Report 2019” @ https://www.businessindustryreports.com/buy-now/162993/single .

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]

+19376349940